Article
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group.
BMC cancer - 11 Oct 2013
Emile Jean-François, Tisserand Julie, Bergougnoux Loic, Nowak Frédérique, Faucher Gladwys, Surel Sylvie, Lamy Aude, Lecorre Delphine, Helias-Rodzewicz Zofia, Hofman Paul, Sabourin Jean-Christophe, Laurent-Puig Pierre
Abstract excerpt
BACKGROUND: Knowledge about tumour gene mutation status is essential for the treatment of increasing numbers of cancer patients, and testing quality has a major impact on treatment response and cost. In 2012, 4,629 tests for BRAF p.V600 were performed in France, in patients with melanomas. METHODS: Two batches of unstained melanoma sections were sent, in May and November 2012, to the 46 laboratories supported by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
